Katherine Giannamore
    • Labeling & Claims
    • FDA Label Reviews
    • Label & Marketing Reviews
    • Ingredient Reviews
    • Supplement Facts Panels
    • Outer Packaging Requirements
    • Website Reviews
    • Nutrient Content Claims
    • Organic & Natural Claims
    • Structure/Function Claims
    • Disease Claims
    • Health Claims
    • Food, Supplements & Devices
    • FDA Food Services
    • Dietary Supplement Services
    • 30-Day Notification (NDI)
    • 510(k) / Premarket Clearance
    • Premarket Approval (PMA)
    • Imports, Enforcement & General Counsel
    • FDA Imports
    • Warning Letter Responses
    • FDA Consultant Services
  • About
  • Food & Drug Blog
  • Contact
(866) 785-0873 Schedule a Consultation

Food & Drug Blog

FDA Approves Bladder Control Drug for OTC Use, Highlighting Rx to OTC Switch

Drugs, NDA, OTC Drugs, Rx to OTC SwitchFDA

On January 25, 2013, the U.S. Food and Drug Administration (“FDA”) announced the approval of the first women’s bladder control product available without a doctor’s prescription. In the past, all bladder control drugs were only available by prescription. This product, …

Read More

FDA Enjoins Beverage Maker’s Operations until it Complies with the FDCA

Beverages, CGMP, Food, HACCP, Injunction, Labeling, Warning LettersFDA

On January 25, 2013, the U.S. Food and Drug Administration (“FDA”) announced that it has entered into a consent decree of permanent injunction with Jonlly Fruits, Inc. (“Company”) and its President, Bartolo Pérez Román. Jonlly Fruits is a frozen fruit, …

Read More

FDA Warns Online Cigarette Retailers for Marketing Violations

FDA, Guidance, Tobacco Products, Warning LettersFDA

In January 2013, the U.S. Food and Drug Administration (”FDA”) sent out several warning letters to online retailers of cigarettes, detailing certain marketing or product statements made that are in violation of federal laws that govern the practice. Several companies …

Read More

FDA Permits Marketing of Device Capable of Testing for 11 Causes of Infectious Gastroentiritis

510(k), de novo classification, FDA, Medical DevicesFDA

On January 14, 2013, the U.S. Food and Drug Administration (FDA) announced that for the first time it will permit marketing for a new diagnostic test that has the ability to simultaneously detect up to eleven (11) prevalent bacterial, viral, …

Read More

Court Finds FDA’s Prohibition of Off-Label Promotion Unconstitutional

Enforcement, FDA, Labeling, off-label promotion, off-label useFDA

On December 3, 2012, the U.S. Court of Appeals for the Second Circuit reversed the conviction of a pharmaceutical sales representative, finding that promotion of FDA-approved drugs for unapproved uses, in and of itself, does not constitute a violation of …

Read More

FDA Actions Highlight New Authority under FSMA

FDA, Food, Food Facility Registration, Food Safety Modernization Act, FSMA, Recalls, SalmonellaFDA

On November 26, 2012, the U.S. Food and Drug Administration (“FDA”) suspended the food facility registration of Sunland, Inc., a New Mexico-based peanut butter plant. Sunland, Inc. has been in the headlines throughout much of 2012 due to a number …

Read More

FDA Investigates Illnesses Linked to Energy Drinks and Supplements

Adverse Events, Beverages, Dietary Supplements, Energy Drinks, FDA, FoodFDA

On November 16, 2012, the U.S. Food and Drug Administration (“FDA”) issued a statement concerning the Agency’s ongoing investigation of reported illnesses and deaths linked to energy drinks and energy shot supplements. Found here, the Statement details the FDA’s efforts …

Read More

Jimmy Dean Initiates Recall for Failure to Declare Allergens

Allergens, FDA, Food, Labeling, RecallsFDA

On November 10, 2012, Jimmy Dean issued a Press Release, explaining how the Company is initiating a voluntary recall of certain of its products due to a labeling error that resulted in undeclared allergens. In particular, the Company is recalling …

Read More

FDA Warns Company for Marketing Medical Device

510(k), Disease Claims, FDA, Labeling, Medical Devices, PMA, Warning LettersFDA

On November 5, 2012, the U.S. Food and Drug Administration (“FDA”) announced recent action the Agency has taken against a Tennessee-based company in connection with the Company’s alleged violations of the Federal Food, Drug and Cosmetic Act (“FFDCA”). According to …

Read More

FDA Targets Online Pharmacies in International Efforts

Drugs, Enforcement, FDA, Medical Devices, Warning LettersFDA

On October 4, 2012, the U.S. Food and Drug Administration (“FDA”) announced that it has taken action as part of an international campaign to protect consumers from illegal online pharmacies. Found here, the FDA’s announcement explains its involvement in the …

Read More

Posts pagination

< Page 1 … Page 9 Page 10 Page 11 … Page 14 >

    Katherine L. Giannamore
    Rated by Super Lawyers


    loading ...
    Shehadeh Giannamore, PLLC

    Toll-free: (866) 785-0873
    Direct: (305) 507-9843
    Email: contact@giannamore-law.com

    Reachable seven days a week · Response within 24 hours

    Practice Areas

    • Food & Beverage
    • Dietary Supplements
    • Cosmetics & Labeling
    • Medical Devices
    • Drugs & OTC
    • Enforcement & Import Defense

    Popular Services

    • FDA Label Reviews
    • Ingredient Reviews
    • FDA Imports
    • Warning Letter Responses
    • 30-Day NDI Notification

    Firm

    • About
    • Food & Drug Blog
    • Contact
    • Google Reviews

    Information shared on this website and blog is for informational purposes only and may not provide the most up-to-date legal and regulatory information, as we do not provide updates to individual articles after publication. Any commentary or legal analysis herein is for general informational purposes and not to be relied upon for individual legal advice and does not establish an attorney-client relationship.

    © 2026 Shehadeh Giannamore, PLLC. All rights reserved.